Noah Pines

Noah Pines

President, Gen, LLC

Noah Pines, former EVP of GfK HealthCare, is principal of market research consultancy Gen LLC.

Most Recent Articles by Noah Pines

Coming face-to-face with advanced cancer

Coming face-to-face with advanced cancer

A relative's illness challenges a pharma consultant's view of industry progress.

Anderson's 360: Signs of Life

Anderson's 360: Signs of Life

With some of the biggest patent expiries due to pass in 2013, the next two years will be important in terms of pharma's return to growth, says Sanford Bernstein's Dr. Tim Anderson in a discussion with Noah Pines

BMS, Abbott HCV pill data suggest competition for Gilead

Abbott and BMS peeled back the curtain on some impressive clinical trial results, suggesting that Gilead may have some competition in the sprint for an all-oral anti-HCV treatment.

Op/Ed: Meningitis crisis and the threat to pharma

Op/Ed: Meningitis crisis and the threat to pharma

The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.

Boehringer Ingelheim prepares to launch oncology franchise

Boehringer Ingelheim has long been associated with treatments for stroke prevention, COPD and HIV/AIDS, but not cancer. That's about to change, if a cornucopia of 13 abstracts presented at the European Society for Medical Oncology (ESMO) is any evidence.

More Articles by Noah Pines

Field the Force

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.